219 related articles for article (PubMed ID: 34327606)
21. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
Yokozawa J; Sasaki T; Ohwada K; Sasaki Y; Ito JI; Saito T; Kawata S
J Gastroenterol; 2009; 44(6):583-91. PubMed ID: 19365601
[TBL] [Abstract][Full Text] [Related]
22. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats.
Ran J; Hirano T; Adachi M
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E227-32. PubMed ID: 15082419
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.
Rector RS; Thyfault JP; Uptergrove GM; Morris EM; Naples SP; Borengasser SJ; Mikus CR; Laye MJ; Laughlin MH; Booth FW; Ibdah JA
J Hepatol; 2010 May; 52(5):727-36. PubMed ID: 20347174
[TBL] [Abstract][Full Text] [Related]
25. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
Nishimura N; Kaji K; Kitade M; Aihara Y; Sato S; Seki K; Sawada Y; Takaya H; Okura Y; Kawaratani H; Moriya K; Namisaki T; Mitoro A; Yoshiji H
BMC Cancer; 2018 Nov; 18(1):1164. PubMed ID: 30477453
[TBL] [Abstract][Full Text] [Related]
26. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
Jia D; Yamamoto M; Otani M; Otsuki M
Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of 3% milled-rice on blood glucose level and serum lipid concentrations in spontaneously non-insulin-dependent diabetic rats.
Izumi Y; Ishibashi G; Nakanishi Y; Kikunaga S
J Nutr Sci Vitaminol (Tokyo); 2007 Oct; 53(5):400-9. PubMed ID: 18079606
[TBL] [Abstract][Full Text] [Related]
28. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Hotta H; Miura T; Miki T; Togashi N; Maeda T; Kim SJ; Tanno M; Yano T; Kuno A; Itoh T; Satoh T; Terashima Y; Ishikawa S; Shimamoto K
Circ Res; 2010 Jan; 106(1):129-32. PubMed ID: 19910577
[TBL] [Abstract][Full Text] [Related]
30. Exogenous thyroxine increases cardiac GLUT4 translocation in insulin resistant OLETF rats.
Mendez DA; Soñanez-Organis JG; Yang X; Vazquez-Anaya G; Nishiyama A; Ortiz RM
Mol Cell Endocrinol; 2024 Sep; 590():112254. PubMed ID: 38677465
[TBL] [Abstract][Full Text] [Related]
31. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.
Sofue T; Kiyomoto H; Kobori H; Urushihara M; Nishijima Y; Kaifu K; Hara T; Matsumoto S; Ichimura A; Ohsaki H; Hitomi H; Kawachi H; Hayden MR; Whaley-Connell A; Sowers JR; Ito S; Kohno M; Nishiyama A
Am J Hypertens; 2012 May; 25(5):604-11. PubMed ID: 22318512
[TBL] [Abstract][Full Text] [Related]
32. Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats.
Kaihara M; Nakamura Y; Sugimoto T; Uchida HA; Norii H; Norii H; Hanayama Y; Makino H
Acta Med Okayama; 2009 Feb; 63(1):35-42. PubMed ID: 19247421
[TBL] [Abstract][Full Text] [Related]
33. Changes in islet capillary angioarchitecture coincide with impaired B-cell function but not with insulin resistance in male Otsuka-Long-Evans-Tokushima fatty rats: dimorphism of the diabetic phenotype at an advanced age.
Mizuno A; Noma Y; Kuwajima M; Murakami T; Zhu M; Shima K
Metabolism; 1999 Apr; 48(4):477-83. PubMed ID: 10206441
[TBL] [Abstract][Full Text] [Related]
34. Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.
Sheldon RD; Laughlin MH; Rector RS
J Appl Physiol (1985); 2014 May; 116(9):1156-64. PubMed ID: 24577062
[TBL] [Abstract][Full Text] [Related]
35. [Regulation of hepatic lipid metabolism by adiponectin via IRS-2 phosphorylation in OLETF rats].
Zhu B; Li CZ; Pan YH; Zhang Y; Zeng YM; Xue YM
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3134-8. PubMed ID: 22340657
[TBL] [Abstract][Full Text] [Related]
36. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
Nagai Y; Yao L; Kobori H; Miyata K; Ozawa Y; Miyatake A; Yukimura T; Shokoji T; Kimura S; Kiyomoto H; Kohno M; Abe Y; Nishiyama A
J Am Soc Nephrol; 2005 Mar; 16(3):703-11. PubMed ID: 15647337
[TBL] [Abstract][Full Text] [Related]
37. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.
Rector RS; Uptergrove GM; Morris EM; Borengasser SJ; Laughlin MH; Booth FW; Thyfault JP; Ibdah JA
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G874-83. PubMed ID: 21350190
[TBL] [Abstract][Full Text] [Related]
38. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
Hosomi N; Noma T; Ohyama H; Takahashi T; Kohno M
Atherosclerosis; 2002 May; 162(1):69-76. PubMed ID: 11947899
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
Zhao ZQ; Luo R; Li LY; Tian FS; Zheng XL; Xiong HL; Sun LT
Can J Diabetes; 2013 Jun; 37(3):156-68. PubMed ID: 24070838
[TBL] [Abstract][Full Text] [Related]
40. α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats.
Jung TS; Kim SK; Shin HJ; Jeon BT; Hahm JR; Roh GS
Liver Int; 2012 Nov; 32(10):1565-73. PubMed ID: 22863080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
